Loading...
Lifeward Ltd (LFWD) is not a good buy for a beginner, long-term investor at this time. The stock exhibits a bearish technical trend, lacks positive trading signals, and has weak financial performance. Additionally, analysts have significantly lowered the price target, which reflects concerns about the company's near-term prospects. The lack of recent positive news or influential trading activity further diminishes the appeal of this stock for investment.
The technical indicators for LFWD are bearish. The MACD histogram is negative and expanding downward, indicating a bearish trend. RSI is at 18.675, signaling the stock is oversold, but this does not confirm a reversal. Moving averages are also bearish, with SMA_200 > SMA_20 > SMA_5. The stock is trading below key support levels, with S1 at 0.514 and S2 at 0.484, suggesting further downside risk.

The company's gross margin increased by 20.62% YoY in Q3 2025, which is a positive indicator of operational efficiency. Analysts maintain a 'Buy' rating, citing operational changes and regulatory wins as potential long-term growth drivers.
Financial performance remains weak, with negative net income and a significant YoY drop in EPS (-42.86%). No recent news, insider trading, or congress trading activity to support the stock.
In Q3 2025, revenue increased by 1.09% YoY to $6,195,000, and net income improved by 2.79% YoY but remains negative at -$3,170,000. EPS dropped significantly by -42.86% YoY to -0.2, indicating worsening profitability. Gross margin improved to 43.7%, up 20.62% YoY, reflecting better cost management.
H.C. Wainwright analyst Swayampakula Ramakanth lowered the price target from $13 to $4.50 but maintained a 'Buy' rating. The analyst cites operational changes, regulatory wins, and payor dynamics as potential growth drivers, but the lowered price target reflects caution.